Skip to main content

Advertisement

Log in

Clinical Risk Factors for Osteoporosis in Ireland and the UK: A Comparison of FRAX and QFractureScores

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Recently two algorithms have become available to estimate the 10-year probability of fracture in patients suspected to have osteoporosis on the basis of clinical risk factors: the FRAX algorithm and QFractureScores algorithm (QFracture). The aim of this study was to compare the performance of these algorithms in a study of fracture patients and controls recruited from six centers in the United Kingdom and Ireland. A total of 246 postmenopausal women aged 50–85 years who had recently suffered a low-trauma fracture were enrolled and their characteristics were compared with 338 female controls who had never suffered a fracture. Femoral bone mineral density was measured by dual-energy X-ray absorptiometry, and fracture risk was calculated using the FRAX and QFracture algorithms. The FRAX algorithm yielded higher scores for fracture risk than the QFracture algorithm. Accordingly, the risk of major fracture in the overall study group was 9.5% for QFracture compared with 15.2% for FRAX. For hip fracture risk the values were 2.9% and 4.7%, respectively. The correlation between FRAX and QFracture was R = 0.803 for major fracture and R = 0.857 for hip fracture (P ≤ 0.0001). Both algorithms yielded high specificity but poor sensitivity for prediction of osteoporosis. We conclude that the FRAX and QFracture algorithms yield similar results in the estimation of fracture risk. Both of these tools could be of value in primary care to identify patients in the community at risk of osteoporosis and fragility fractures for further investigation and therapeutic intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Melton LJ, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915–1923

    Article  PubMed  Google Scholar 

  2. Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I et al (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11:669–674

    Article  PubMed  CAS  Google Scholar 

  3. Schuit SC, Van der Klift M, Weel AE, De Laet C, Burger H et al (2004) Fracture incidence and association with bone mineral density in elderly mean and women: the Rotterdam study. Bone 34:195–202

    Article  PubMed  CAS  Google Scholar 

  4. Organisation World Health (2004) WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level. WHO, Brussels

    Google Scholar 

  5. Kanis JA, Johnell O, De Laet C, Johansson H, Oden A et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382

    Article  PubMed  CAS  Google Scholar 

  6. Kanis JA, Johansson H, Oden A, Johnell O, De Laet C et al (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029–1037

    Article  PubMed  CAS  Google Scholar 

  7. Kanis JA, Johansson H, Oden A, Johnell O, de Laet C et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899

    Article  PubMed  Google Scholar 

  8. Kanis JA, Johnell O, Oden A, Johansson H, De Laet C et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:222–228

    Article  PubMed  Google Scholar 

  9. Kanis JA, Johansson H, Johnell O, Oden A, De Laet C et al (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742

    Article  PubMed  Google Scholar 

  10. Kanis JA, Johansson H, Oden A, De Laet C, Johnell O et al (2005) A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int 16:799–804

    Article  PubMed  Google Scholar 

  11. De Laet C, Kanis JA, Odén A, Johanson H, Johnell O et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–1338

    Article  PubMed  Google Scholar 

  12. De Laet C, Odén A, Johansson H, Johnell O, Jönsson B et al (2005) The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 16:313–318

    Article  PubMed  Google Scholar 

  13. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O et al (2005) Assessment of fracture risk. Osteoporos Int 16:581–589

    Article  PubMed  Google Scholar 

  14. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046

    Article  PubMed  CAS  Google Scholar 

  15. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A et al (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244

    Article  PubMed  Google Scholar 

  16. Ward KD, Klesges RC (2001) A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 68:259–270

    Article  PubMed  CAS  Google Scholar 

  17. Berg KM, Kunins HV, Jackson JL, Nahvi S, Chaudhry A et al (2008) Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med 121:406–418

    Article  PubMed  CAS  Google Scholar 

  18. Hippisley-Cox J, Coupland C (2009) Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 339:b4229

    Article  PubMed  Google Scholar 

  19. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C et al (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20:1185–1194

    Article  PubMed  Google Scholar 

  20. Cummings SR, Nevitt MC (1994) Non-skeletal determinants of fractures: the potential importance of the mechanics of falls. Study of Osteoporotic Fractures Research Group. Osteoporos Int 4:67–70

    Article  PubMed  Google Scholar 

  21. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397

    Article  PubMed  CAS  Google Scholar 

  22. Black DM, Arden NK, Palermo L, Pearson J, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res 14:821–828

    Article  PubMed  CAS  Google Scholar 

  23. Compston J, Cooper A, Cooper C, Francis R, Kanis JA et al (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62:105–108

    Article  PubMed  CAS  Google Scholar 

  24. Ensrud KE, Lui LY, Taylor BC, Schousboe JT, Donaldson MG et al (2009) A comparison of prediction models for fractures in older women: is more better? Arch Int Med 169:2087–2094

    Article  Google Scholar 

  25. Pluskiewicz W, Adamczyk P, Franek E, Leszczynski P, Sewerynek E et al (2010) 10-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.—conformity between methods and their clinical utility. Bone 46:1661–1667

    Article  PubMed  CAS  Google Scholar 

  26. Kanis JA, Oden A, Johanson H, Borgstrom F, Strom O et al (2009) FRAX and its applications to clinical practice. Bone 44:734–743

    Article  PubMed  Google Scholar 

  27. Siris ES, Simon JA, Barton IP, McClung MR, Grauer A (2008) Effects of risedronate on fracture risk in postmenopausal women with osteopenia. Osteoporos Int 19:681–686

    Article  PubMed  CAS  Google Scholar 

  28. Rogers A, Glover SJ, Eastell R (2009) A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy. Bone 45:1044–1052

    Article  PubMed  CAS  Google Scholar 

  29. Finkelstein JS, Wyland JJ, Lee H, Neer RM (2010) Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 95:1838–1845

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge the financial support of the Enterprise Ireland Innovation Partnership grant board. The authors also sincerely acknowledge the assistance of all the participating subjects.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. M. Cummins.

Additional information

The authors have stated that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cummins, N.M., Poku, E.K., Towler, M.R. et al. Clinical Risk Factors for Osteoporosis in Ireland and the UK: A Comparison of FRAX and QFractureScores. Calcif Tissue Int 89, 172–177 (2011). https://doi.org/10.1007/s00223-011-9504-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-011-9504-2

Keywords

Navigation